Back to results
US 2012/0252838 A1Published application
Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
AssigneeEli Lilly and Company
InventorsLourdes Prieto, Lorena Taboada Martinez
Life of this patent
Estimating the term…
Abstract
The present invention provides certain tetrahydrotriazolopyridine derivatives, pharmaceutical compositions thereof, methods of using the same and processes for preparing the same. Formula (I) wherein R1 is hydrogen, fluoro, chloro, or methyl; and R2 is C4-CS branched alkyl.
Claims10
A compound of the formula or a pharmaceutically acceptable salt thereof
- wherein
- R1 is hydrogen, fluoro, chloro or methyl;
- and
- R2 is C4-C5 branched alkyl.
1 more element
(canceled)
(canceled)
A process for preparing a compound of formula I, or a pharmaceutically acceptable salt thereof, comprising
- A) for a compound of formula I,
- wherein
- R1 is hydrogen, fluoro, chloro or methyl;
- and
- R2 is C4-C5 branched alkyl;
- condensing of a compound of formula VII with a compound of formula II wherein R3 is C1-C3 alkyl
- or alternatively
- B) for a compound of formula I, condensing an R2-acyl hydrazine with a compound of formula III wherein X is O or S, and R4 is C1-C3 alkyl.
- whereafter, when a pharmaceutically acceptable salt of the compound of formula I is desired, it is obtained by reacting a basic compound of formula I with a physiologically acceptable acid.
6 more elements
Dependencies are inferred from the claim text.